{"database": "openregs", "table": "documents", "rows": [["FDA-2014-D-2175-0010", "FDA", "FDA-2014-D-2175", "Reference  7 - Photochemical Treatment of Plasma with Amotosalen and Longwavelength Ultraviolet Light Inactivates Pathogens while Retaining\nCoagulation Function re Recommendations for Assessment of Blood Donor Suitability, Donor Deferral and Blood Product Management in Response to Ebola Virus; Draft Guidance for Industry; Availability", "Supporting & Related Material", "Background Material", "2015-12-07T05:00:00Z", 2015, 12, null, null, "2015-12-07T14:40:40Z", null, 0, 0, "0900006481d8411e"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-D-2175-0010"], "units": {}, "query_ms": 14.714239980094135, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}